Celcuity(CELC.US)

Event Tracking

Dec12

Wells Fargo Upgrades Celcuity to Outperform with $126 Price Target

20:07

Dec11

Celcuity Inc. Announces Positive Phase 3 Clinical Trial Results for Gedatolisib in Breast Cancer

19:35

Dec9

Celcuity Inc. Director Sells Common Stock

21:24

Nov26

Celcuity Announces Results of Phase III Trial for Gedatolisib

21:05

Nov25

Celcuity Shares Reach a 52-Week High With Earnings Exceeding Expectations

23:25

Nov24

Celcuity Inc. Director David Dalvey Sells Common Stock

21:07

Schedules & Filings

Schedules

Filings

Nov12

Earning Release(EST)

FY2025 Q3 Earning Release (USD) Net Income -43.8 M, EPS -0.9204

Aug14

Earning Release(EST)

FY2025 Q2 Earning Release (USD) Net Income -45.27 M, EPS -1.0367

May14

Earning Release(EST)

FY2025 Q1 Earning Release (USD) Net Income -37 M, EPS -0.8593

Stock List

Top Gainers

Top Decliners

China Concepts

Symbol

Price

%Chg

Change